You are here

Article info

Article menu

Download PDFPDF

Commentary
Acknowledging and addressing real-world challenges to treating immune-related adverse events

Authors

  • Mitchell S von Itzstein Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USAHarold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • David E Gerber Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USAHarold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas, USAO’Donnell School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Bonnie L Bermas Division of Rheumatic Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Alexa Meara Division of Medical Oncology Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA PubMed articlesGoogle scholar articles

Citation

von Itzstein MS, Gerber DE, Bermas BL, et al
Acknowledging and addressing real-world challenges to treating immune-related adverse events
Journal for ImmunoTherapy of Cancer 2024;12:e009540. doi: 10.1136/jitc-2024-009540
Online issue publication 
July 22, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.